GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

NCT03821129 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
636
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

W.L.Gore & Associates